COLORADO DENVER UNIVERSITY OF

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy

Phase 2

Completed

Conditions: Gynecologic Cancer
Venous Thromboembolism

Interventions: Drug: Oral apixaban
Drug: Subcutaneous enoxaparin

First Posted Date: 2015-02-19

Last Posted Date: 2020-03-31

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 400

Registration Number: NCT02366871

Locations: 🇺🇸
University of Southern California Keck School of Medicine, Los Angeles, California, United States
🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

Aspiration in Acute Respiratory Failure Survivors

Not Applicable

Completed

Conditions: Dysphagia

Interventions: Procedure: FEES
Procedure: BSE

First Posted Date: 2015-02-16

Last Posted Date: 2021-07-12

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 248

Registration Number: NCT02363686

Locations: 🇺🇸
Boston University Medical Center, Boston, Massachusetts, United States
🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States
🇺🇸
Yale University, New Haven, Connecticut, United States

Drug Metabolizing Enzyme and Transporter Function in Chronic Kidney Disease

Not Applicable

Completed

Conditions: Deficiency, Vitamin D
Chronic Kidney Diseases

Interventions: Dietary Supplement: Cholecalciferol

First Posted Date: 2015-02-10

Last Posted Date: 2021-06-30

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 23

Registration Number: NCT02360644

Locations: 🇺🇸
University of Colorado, Aurora, Colorado, United States
🇺🇸
University of Pittsburgh, Pittsburgh, Pennsylvania, United States

Bortezomib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant

Phase 2

Terminated

Conditions: Refractory Plasma Cell Myeloma

Interventions: Drug: Bortezomib
Drug: Lenalidomide
Drug: Dexamethasone

First Posted Date: 2015-02-02

Last Posted Date: 2015-03-09

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 3

Registration Number: NCT02353468

Locations: 🇺🇸
University of Colorado, Aurora, Colorado, United States

Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

Phase 1

Terminated

Conditions: Plasma Cell Myeloma
Recurrent Plasma Cell Myeloma
Plasmacytosis
Smoldering Plasma Cell Myeloma

Interventions: Drug: Melphalan
Drug: Bortezomib
Drug: Dexamethasone
Procedure: Autologous Transplant

First Posted Date: 2015-02-02

Last Posted Date: 2015-03-09

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 3

Registration Number: NCT02353572

Locations: 🇺🇸
University of Colorado Cancer Center, Aurora, Colorado, United States

Neuronal and Behavioral Effects of Implicit Priming in Obese Individuals

Not Applicable

Completed

Conditions: Feeding Behavior
Overweight
Obesity

Interventions: Behavioral: Control Implicit Priming
Behavioral: Active Implicit Priming

First Posted Date: 2015-01-27

Last Posted Date: 2022-09-07

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 92

Registration Number: NCT02347527

Locations: 🇺🇸
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

Cognitive Dysfunction in Parkinson's Disease

Not Applicable

Completed

Conditions: Parkinson's Disease

Interventions: Device: Real TMS
Device: Sham TMS

First Posted Date: 2015-01-27

Last Posted Date: 2021-02-09

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 49

Registration Number: NCT02346708

Locations: 🇺🇸
University of Colorado School of Medicine, Aurora, Colorado, United States

PCORI-1310-06998 Trial of a Decision Support Intervention for Patients and Caregivers Offered Destination Therapy Heart Assist Device

Not Applicable

Completed

Conditions: Heart Failure
Heart-assist Devices

Interventions: Behavioral: DT LVAD Decision Support Intervention

First Posted Date: 2015-01-26

Last Posted Date: 2020-03-19

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 445

Registration Number: NCT02344576

Locations: 🇺🇸
Washington University School of Medicine in St.Louis, Saint Louis, Missouri, United States
🇺🇸
University of Colorado School of Medicine, Aurora, Colorado, United States
🇺🇸
St. Vincent Indianapolis Hospital, Indianapolis, Indiana, United States

and more 3 locations

Evaluation of Potential Allergenicity of New Wheat Varieties

Terminated

Conditions: Food Allergy
Wheat Allergy

First Posted Date: 2015-01-19

Last Posted Date: 2018-05-21

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 5

Registration Number: NCT02341040

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

A Randomized, Double-Blind Study of Placebo vs. Ketamine For Use During Dressing Changes in Critically Ill Burn Patients

Phase 4

Withdrawn

Conditions: Thermal Hyperalgesia
Anxiety
Pain

Interventions: Drug: Placebo, Normal Saline
Drug: Ketamine

First Posted Date: 2015-01-12

Last Posted Date: 2015-11-26

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT02336308

Locations: 🇺🇸
University of Colorado, Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy